Doctolib — Valuation, Funding & Investors

Doctolib operates a healthtech platform used by medical professionals across France, Germany and Italy, combining appointment booking, telemedicine and practice-management tools into one system. Patients use the same platform to book visits online, while doctors use it for scheduling, messaging and back-office operations. Stanislas Niox-Chateau and four co-founders started Doctolib in Paris in 2013; the company is headquartered in the Paris region, in Levallois-Perret.

Doctolib became the most valuable French startup in 2022, and it now employs more than 2,800 people across more than 30 European cities. It expanded from a pure booking system into telemedicine, messaging and electronic health records during the pandemic.

Listed funds carry late-stage private names. A fund's latest schedule of investments shows whether it holds Doctolib.

Often trade at a premium or discount to NAV.

Platforms match existing holders with buyers. Doctolib availability at any moment is set by the holders.

High minimums, transfer approval, company right-of-first-refusal.

Valuations, rounds and IPO status for every company in the directory — Doctolib included.

The last valuation is $6.4B.

Lead investors for each round are in the funding timeline.

The closest healthtech / medical appointment booking peers are on the competitors page.

The routes section explains what is realistically available for a company at this stage.